Epidemiology of primary liver cancer

Cancer Forum

Volumn 33, Issue 2, 2009, Pages 88-92

  Alam, Noore ^a   Robotin, Monica ^b,c   Baker, Deborah ^a  

^a CANCER INSTITUTE NSW   (Australia)

^b CANCER RESEARCH DIVISION   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICA; ASIA; AUSTRALIA; CANCER MORTALITY; CANCER RISK; HEPATITIS B; HEPATITIS C; HUMAN; IMMIGRATION; INCIDENCE; LIVER CANCER; MORBIDITY; NONHUMAN; REVIEW; VIRUS HEPATITIS;

EID: 69249164370     PISSN: 0311306X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology. 2004;127(5 Suppl 1):S5-S16. (Pubitemid 39423365)
2. Bartlett DL, Carr BI, Marsh JW. Cancers of the gastrointestinal tract: section 4: cancer of the liver. In: DeVita VJ, Hellman S, Rosenberg S, editors. Principles and Practice of Oncology (7th). Philadelphia: Lippincott Williams & Wilkins; 2005.
3. World Cancer Research Fund / American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington DC: AICR; 2007.
4. Bosch FX, Ribes J, Cleries R, Diaz M. Epidemiology of hepatocellular carcinoma. Clin Liver Dis. 2005;9:191-211.
5. Yuen M-F. Revisiting the natural history of chronic hepatitis B: impact of new concepts on clinical management. J Gastroenterol Hepatol. 2007;22:973-976. (Pubitemid 47019865)
6. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108.
7. Ferlay J. GLOBOCAN 2002. Descriptive Epidemiology Group, Biostatistics and Epidemiology Cluster. Lyon: International Agency for Research on Cancer; 2005.
8. Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LA, et al. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst. 2005;97:1407-1427
9. Seeff LB, Hoofnagle JH. Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity. Oncogene. 2006;25:3771-3777
10. Visser O, van Leeuwen FE. Cancer risk in first generation migrants in North-Holland/Flevoland, The Netherlands, 1995-2004. Eur J Cancer. 2007;43:901-908
11. McCracken M, Olsen M, Chen MS, Jr., Jemal A, Thun M, Cokkinides V, et al. Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities. CA Cancer J Clin. 2007;57:190-205. (Pubitemid 47312080)
12. Simmons GC, Yeong ML, Lee SP. The association of hepatitis B viral infection and hepatocellular carcinoma in New Zealand. N Z Med J. 1983;96:669-671 (Pubitemid 14206617)
13. King H, Locke FB. Cancer mortality among Chinese in the United States. J Natl Cancer Inst. 1980;65:1141-1148 (Pubitemid 11215044)
14. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907-1917.
15. Alam N, Chen W, Baker D, Bishop J. Liver Cancer in New South Wales. Sydney: Cancer Institute NSW; 2009.
16. World Cancer Research Fund and American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington DC: AICR; 2007.
17. Tracey E, Alam N, Chen W, Bishop J. Cancer in New South Wales: incidence and mortality 2006. Sydney: Cancer Institute NSW; 2008.
18. Law MG, Roberts SK, Dore GJ, Kaldor JM. Primary hepatocellular carcinoma in Australia, 1978-1997: increasing incidence and mortality. Med J Aust. 2000;173:403-405
19. Australian Institute of Health and Welfare and Australasian Association of Cancer Registries. Cancer in Australia: an overview, 2006. Cancer series no. 37, AIHW cat. no. CAN 32. Canberra: Australian Government; 2007.
20. McDermid I. Cancer incidence projections, Australia 2002 to 2011. Canberra: Australian Institute of Health and Welfare (AIHW), Australasian Association of Cancer Registries (AACR) and the National Cancer Strategies Group (NCSG); 2005.
21. Australian Government Department of Health and Ageing. National Notifiable Diseases Surveillance System (NNDSS). Canberra: Australian Government; 2008 [cited 2008 Feb 19]. Available from: http://www9.health.gov.au/ cda/Source/CDA-index.cfm.
22. Dore G, Wallace J, Locarnini S, Desmond P, Gane E, Crawford DH. Hepatitis B in Australia: responding to a diverse epidemic. Sydney; 2006.
23. Liaw YF, Sollano JD. Factors influencing liver disease progression in chronic hepatitis B. Liver Int. 2006;26 Suppl 2:23-29
24. Wan X, Mathews JD. Primary hepatocellular carcinoma in aboriginal Australians. Aust J Public Health. 1994;18:286-290
25. O'Sullivan BG, Gidding HF, Law M, Kaldor JM, Gilbert GL, Dore GJ. Estimates of chronic hepatitis B virus infection in Australia, 2000. Aust N Z J Public Health. 2004;28:212-216
26. Nguyen VT, Dore GJ. Prevalence and epidemiology of hepatitis B. In: Matthews G, Robotin M, editors. B Positive- all you wanted to know about hepatitis B. Sydney: Australasian Society for HIV Medicine (ASHM); 2008.
27. Condon JR, Barnes T, Cunningham J, Armstrong BK. Long-term trends in cancer mortality for Indigenous Australians in the Northern Territory. Med J Aust. 2004;180:504-507. (Pubitemid 38684617)
28. NSW Department of Health. The Health of the People of New South Wales: Report of the Chief health Officer, 2006. Sydney: Population Health Division, NSW Department of Health; 2006.
29. Tracey E, Chen S, Baker D, Bishop J, Jelfs P. Cancer in New South Wales: Incidence and Mortality 2004. Sydney: Cancer Institute NSW; 2006.
30. Supramaniam R, O'Connell DL, Tracey E, Sitas F. Cancer incidence in New South Wales migrants 1991 to 2001. Sydney: The Cancer Council NSW; 2006.
31. Gellert L, Jalaludin B, Levy M. Hepatocellular carcinoma in Sydney South West: late symptomatic presentation and poor outcome for most. Intern Med J. 2007;37:516-522. (Pubitemid 47084172)
32. Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med. 1997;336:1855-1859
33. O'Sullivan BG, Gidding HF, Law M, Kaldor JM, Gilbert GL, Dore GJ. Estimates of chronic hepatitis B virus infection in Australia, 2000. Aust N Z J Public Health. 2004;28:212-216
34. Nguyen VT, Razali K, Amin J, Law MG, Dore GJ. Estimates and projections of hepatitis B-related hepatocellular carcinoma in Australia among people born in Asia-Pacific countries. J Gastroenterol Hepatol. 2008;23:922-929 (Pubitemid 351806566)
35. Amin J, Dore GJ, O'Connell DL, Bartlett M, Tracey E, Kaldor JM, et al. Cancer incidence in people with hepatitis B or C infection: a large community-based linkage study. J Hepatol. 2006;45:197-203.
36. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet. 1981;2:1129-1133
37. Chu CM. Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma. J Gastroenterol Hepatol. 2000;15 Suppl(E25-30).
38. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004;11:97-107. (Pubitemid 38365759)
39. Liu J, Fan D. Hepatitis B in China. Lancet. 2007;369:1582-1583
40. Smith JB, Blumberg BS. Viral hepatitis, postnecrotic cirrhosis, and hepatocellular carcinoma. Lancet. 1969;2:953.
41. Yu MW, Chen CJ. Hepatitis B and C viruses in the development of hepatocellular carcinoma. Critical Review of Oncologic Hematology. 1994;17:71-91.
42. Tanaka K, Ikematsu H, Hirohata T, Kashiwagi S. Hepatitis C virus infection and risk of hepatocellular carcinoma among Japanese: possible role of type Ib (II) infection. J Natl Cancer Inst. 1996;88:742-746. (Pubitemid 26195022)
43. Yu M-W, You S, Chang A, Lu S, Liaw Y, Chen C. Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan. Cancer Res. 1991;51:5621-5625.
44. De Masi S, Tosti ME, Mele A. Screening for hepatocellular carcinoma. Dig Liver Dis. 2005;37:260-268
45. Schiff ER. Prevention of mortality from hepatitis B and hepatitis C. Lancet. 2006;368:896-897.
46. Singal AK, Anand BS. Mechanisms of synergy between alcohol and hepatitis C virus. J Clin Gastroenterol. 2007;41:761-772 (Pubitemid 47267763)
47. Harris DR, Gonin R, Alter HJ, Wright EC, Buskell ZJ. The relationship of acute transfusion-associated hepatitis to the development of cirrhosis in the presence of alcohol abuse. Ann Intern Med. 2001;134:120-124. (Pubitemid 32096339)
48. Serra M, Rodríguez F, del Olmo J, Escudero A, Rodrigo J. Influence of age and date of infection on distribution of hepatitis C virus genotypes and fibrosis stage. J Viral Hepat. 2003;10:183-188. (Pubitemid 36629666)
49. Thomas DL, Astemborski J, Rai R, Anania F, Schaeffer M, Galai N, et al. The Natural History of Hepatitis C Virus Infection: Host, Viral, and Environmental Factors. JAMA. 2000;284:450-456.
50. International Agency for Research on Cancer. Tobacco Smoke and Involuntary Smoking. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans; 2002 [cited 2009 March 20]. Available from: http://monographs.iarc.fr/ ENG/Monographs/vol83/volume83.pdf.
51. Corrao G, Ferrari P, Galatola G. Exploring the role of diet in modifying the effect of known disease determinants: application to risk factors of liver cirrhosis. Am J Epidemiol. 1995;142:1136-1146.
52. Klatsky A, Armstrong M. Alcohol, smoking, coffee, and cirrhosis. Am J Epidemiol. 1992;136:1248-1257.
53. Yu M-W, Hsu F-C, Sheen I-S, Chu C-M, Lin D-Y, Chen C-J, et al. Prospective study of Hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. Am J Epidemiol. 1997;145:1039-1047. (Pubitemid 27215487)
54. Adami H-O, Chow W-H, OlofNyren CB, Linet MS, Ekbom A, Wolk A, et al. Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst. 1996;88:1472-1477. (Pubitemid 26340049)
55. Gallus S, Bertuzzi M, Tavani A, Bosetti C, Negri E, Vecchia CL, et al. Does coffee protect against hepatocellular carcinoma? Br J Cancer. 2002;87:956-959.
56. Kita Y, Mizukoshi E, Takamura T, Sakurai M, Takata Y, Arai K, et al. Impact of diabetes mellitus on prognosis of patients infected with hepatitis C virus. Metabolism. 2007;56:1682-1688 (Pubitemid 350060935)
57. Wong LL, Lurie F, Takanishi DM, Jr. Other primary neoplasms in patients with hepatocellular cancer: prognostic implications? Hawaii Med J. 2007;66:204.
58. Ioannou GN, Splan MF, Weiss NS, McDonald GB, Beretta L, Lee SP. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis. Clinical Gastroenterology & Hepatology. 2007;5:938-945 (Pubitemid 47127020)
59. Oh SW, Yoon YS, Shin S-A. Effects of excess weight on cancer incidences depending on cancer sites and histologic findings among men: Korea National Health Insurance Corporation study. J Clin Oncol. 2005;23:4742-4754.
60. Samanic C, Chow W-H, Gridley G, Jarvholm B, Fraumeni JF, Jr. Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control. 2006;17:901-909
61. Tawk HM, Vickery K, Bisset L, Lo SK, Selby W, Cossart YE. The current pattern of hepatitis B virus infection in Australia. J Viral Hepat. 2006;13:206-215
62. Craxi A, Camma C. Prevention of hepatocellular carcinoma. Clin Liver Dis. 2005;9:329-346